$131 Million is the total value of JGP Global Gestao de Recursos Ltda.'s 59 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VLATU | VALOR LATITUDE ACQUISITION Cunit | $10,769,000 | -0.2% | 1,100,000 | 0.0% | 8.19% | +32.1% | |
| STNE | ITIQUIRA ACQUISITION CORPunit | $8,865,000 | -0.9% | 900,000 | 0.0% | 6.74% | +31.3% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $225,000 | +7.7% | 2,713 | 0.0% | 0.17% | +42.5% | |
| OIBRC | OI SA-ADRadr | $178,000 | -65.4% | 575,000 | 0.0% | 0.14% | -54.4% | |
| SBRCY | SBERBANK PJSC - SPONSORED ADRadr | $7,000 | 0.0% | 160,000 | 0.0% | 0.01% | +25.0% | |
| RBLX | ROBLOX CORP -CLASS Acall | $0 | -100.0% | 300 | 0.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BMRN | 30 | Q3 2023 | 2.8% |
| INCYTE CORP | 28 | Q3 2023 | 3.9% |
| VERTEX PHARMACEUTICALS INC | 26 | Q3 2023 | 3.9% |
| LILLY ELI & CO | 26 | Q3 2023 | 1.3% |
| REGENERON PHARMACEUTICALS | 26 | Q3 2023 | 1.6% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2023 | 5.9% |
| ACADIA PHARMACEUTICALS INC | 24 | Q3 2023 | 0.7% |
| THERMO FISHER SCIENTIFIC INC | 21 | Q3 2023 | 4.7% |
| ABBVIE INC | 21 | Q3 2023 | 1.9% |
| HUMANA INC | 21 | Q3 2023 | 1.6% |
View JGP Global Gestao de Recursos Ltda.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-19 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-04 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-05 |
| SC 13G | 2022-02-11 |
| 13F-HR | 2022-02-03 |
View JGP Global Gestao de Recursos Ltda.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.